Baxter touts Theranova HDx dialysis tech study data

May 31, 2018 By Fink Densford Leave a Comment

Baxter (NYSE:BAX) today released new data from studies exploring expanded hemodialysis with its Theranova dialyzer, touting the device’s ability to clear large middle molecules at a higher rate than standard hemodialysis and equal or faster removal rates compared to high-volume hemodiafiltration.

Results from a number of studies and poster presentations on the Theranova dialyzer were presented at the 55th Congress of the European Renal Association and European Dialysis and Transplant Association meeting this month, Baxter said.

The Deerfield, Ill.-based company’s Theranova dialyzer is designed to extend the range of molecules that it filters from the blood, which the company claims “more closely mimics the natural kidney.” The expanded hemodialysis therapy works on standard equipment and does not require the generation of replacement fluid, Baxter said.

Baxter touted that data from two studies presented at the meeting indicated that during treatment with the Theranova dialyzer, albumin levels remained stable during treatment.

In an independent study exploring the effects of its HDx therapy in comparison to high-flux HD in conventional settings, data indicated no loss of serum albumin or serum protein with use of the Theranova dialyzer in conventional HD compared to high-flux dialyzer hemodiafiltration. No relevant differences in adequacy, anemia or bone mineral metabolism parameters were noted, Baxter added.

A separate independent study, researchers found Baxter’s HDx to be superior to standard high-flux HD in removing middle and larger molecules, and found it non-inferior to hemodiafiltration in clearing small and larger middle molecules.

“HDx therapy enabled by Theranova was designed to filter a wider range of toxins from the blood than conventional HD filters, because we believe this is a critical step to transforming renal care and improving patient outcomes. We are committed to fully exploring and supporting robust scientific exchange about HDx therapy to understand its full potential for dialysis patients,” Baxter renal care biz GM Laura Angelini said in a press release.

Earlier this week, Baxter announced the launch of two updates for its Sharesource remote patient monitoring platform designed to monitor home peritoneal dialysis patients including the addition of a new modeling software tool and improvements to the clinical portal.

DeviceTalks Boston is Bigger and Better than Ever!

Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it all began.

DeviceTalks offers three days of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.

Early Registration is now open.

3D color X-rays could help diagnose cancer, heart disease and more
New Zealand scientists performed the first-ever 3D, color X-rays on a human, using technology that could improve medical diagnostics in oncology, cardiology, neurology and orthopedics. Based on traditional black-and-white X-ray technology, the scanner incorporates the Medipix3RX detector chip, a particle-tracking technology developed for the CERN Large Hadron Collider. It was developed by the Medipix3 Collaboration, which […]
Band-aid-like patch boosts fluorescence brightness in diagnostic tests
Researchers at Washington University in St. Louis have created a high-tech metal nanostructure patch that increases fluorescence intensity by 100 times in medical diagnostic tests. Fluorescence-based biosensing and bioimaging technologies have been used to detect and image different biological species. It is convenient to use, but they have poor sensitivity. For example, the fluorescent signal […]
Digital Surgery touts artificial intelligence for the operating room
Officials at Digital Surgery (London) boast that they have successfully demonstrated a real-time, dynamic artificial intelligence (AI) system designed for the operating room. The patented AI platform includes surgical procedure roadmaps that are meant to aid the surgical team in an OR. The goal is to reduce risk and make surgery safer. “This is a huge milestone for […]
9 trends in medical device user interface design
By Valerie Ng and Jon Tilliss, Emergo Group As the influence of technology in our everyday lives continues to grow, the standard for aesthetically pleasing and contemporary user interface (UI) designs in the healthcare space continues to evolve. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post […]
Key Surgical acquires Encompas Unlimited
Key Surgical recently announced that it has acquired Encompas Unlimited to expand its endoscopy product offerings. The financial details of the deal were not disclosed. This is the second acquisition that Key Surgical has completed after merging with Interlock Medizintechnik last year. Emcompas specializes in manufacturing, assembling and distribution a variety of endoscopy accessories and […]
Here are the top 5 medtech stories of mid-2018
A growing U.S. trade war with China and other countries casts a pall on medtech — and U.S. business in general — in mid-2018. The landscape of the medical device industry continues to evolve, though. There’s a major corporate spinout in the works, as well as a mega-merger that apparently was not to be. Read […]
Medtech stories we missed this week: July 13, 2018
From Angiodroid receiving CE Mark approval to Masimo launching its vital signs app, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Angiodroid wins CE Mark for Angiopulse IABP Angiodroid announced in a July 11 press releasethat it has received CE Mark approval for its AngioPulse intra-aortic balloon pump […]
OCTANe wraps up Ophthalmology Technology Summit
OCTANe recently hosted its annual Ophthalmology Technology Summit (OTS) where hundreds of industry leaders, investors and physicians attended to learn about ophthalmology trends and innovations. The company says that the event say significant growth this year with over 400 attendees at the conference, which is a 35% increase in attendance, year-over-year. oTS is designed to […]
Who’s afraid of the big, bad PMAs?
PMAs at FDA are often a scary process for medical devices developers. But that doesn’t have to be the case, according to Michael Drues, a regulatory consultant based outside Boston who has worked with both medical device companies and FDA. There are many myths around premarket approval, such as the idea that PMAs always require […]
Gerresheimer to acquire Sensile Medical and its drug-delivery tech
Gerresheimer plans to acquire Swiss medical technology company Sensile Medical and its array of liquid drug delivery devices. The buyout is a perfect fit in Gerresheimer’s portfolio, the company explained, since it will boost Gerresheimer’s drug delivery offerings and add new digital and electronic capabilities into the mix. Get the full story at our sister site, Drug Delivery […]
GW Plastics promotes new leaders to executive team
GW Plastics recently announced that it has appointed three new leaders to its executive team. Cathy Tempesta has been appointed to VP of human resources at GW Plastics. She has been with the company for 15 years as the director of human resources. Tempesta will be responsible for bringing the best practices to GW Plastics’s […]